Patrick Baeuerle Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Patrick Baeuerle.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Patrick Baeuerle. Patrick Baeuerle is a SVP, Chief Scientific Officer in MICROMET, INC. ($MITI) and a Director in Harpoon Therapeutics, Inc. ($HARP) and a Director in TCR2 THERAPEUTICS INC. ($TCRR) and a See Remarks in Cullinan Management, Inc. ($CGEM).
Address: C/O MICROMET, INC. STAFFELSEESTRASSE 2 MUNICH 81477Germany
Companies in which Patrick Baeuerle is an Insider
Cullinan Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Patrick Baeuerle: See Remarks
Holdings: 0 shares
Latest Transaction: Jan 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Harpoon Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Patrick Baeuerle: Director
Holdings: 273,953 shares
Latest Transaction: Jun 01 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MICROMET, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Patrick Baeuerle: SVP, Chief Scientific Officer
Holdings: 22,563 shares
Latest Transaction: Apr 05 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TCR2 THERAPEUTICS INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Patrick Baeuerle: Director
Holdings: 435,693 shares
Latest Transaction: Dec 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Patrick Baeuerle
Sentiment: All, CGEM, HARP, MITI, TCRR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 11 2021 | CGEM | Cullinan Managemen ... | Baeuerle Patrick | See Remarks | Option Exercise | A | 21.00 | 286,665 | 6,019,965 | 286,665 | |
| Dec 11 2020 | TCRR | TCR2 THERAPEUTICS ... | Baeuerle Patrick | Director | Option Exercise | A | 31.83 | 12,100 | 385,143 | 12,100 | |
| Jun 01 2020 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Option Exercise | A | 20.59 | 2,584 | 53,205 | 2,584 | |
| Jun 01 2020 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Option Exercise | A | 20.59 | 10,167 | 209,339 | 10,167 | |
| Dec 30 2019 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Sell | S | 18.07 | 1,400 | 25,297 | 262,136 | 263.5 K to 262.1 K (-0.53 %) |
| Dec 30 2019 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Sell | S | 16.90 | 10,417 | 176,062 | 263,536 | 274 K to 263.5 K (-3.80 %) |
| Dec 30 2019 | HARP | Harpoon Therapeuti ... | Baeuerle Patrick | Director | Sell | S | 15.81 | 75,562 | 1,194,922 | 273,953 | 349.5 K to 274 K (-21.62 %) |